x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Decera Clinical Education Infectious Disease Podcast

Decera Clinical Education

Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Decera Clinical Education. Gain practical strategies and earn CME/CE credit for selected episodes.

education courses

All Episodes

00:42:39

Key Decisions in HIV Care: ART in Pregnancy

Decera Clinical Education Infectious Disease Podcast ·

2021/11/08

In this episode from the series “Key Decisions in HIV Care,” Milena Murray, PharmD, MSc, BCIDP, AAHIVP, and Jonah Musa, MBBS, MSCI, PhD, discuss important considerations for ART use in pregnancy, including DHHS and WHO guideline recommendations and data supporting recommended ART regimen options in pregnancy from IMPAACT 2010, Tsepamo, and DoLPHIN-2. They also discuss pharmacokinetic considerations and drug–drug interactions. Following their dialogue, the faculty field questions from healthcare

en

00:55:38

Key COVID-19 Studies Influencing My Practice...

Decera Clinical Education Infectious Disease Podcast ·

2021/10/29

In this episode, Renslow Sherer, MD, discusses new COVID-19 data from IDWeek 2021, including:Prevention of COVID-19ChAdOx1 nCoV-19Ad26.COV2.STixagevimab plus cilgavimabOutpatients with COVID-19Remdesivir IVMolnupiravirHospitalized patients with COVID-19BaricitinibLenzilumabCasirivimab plus imdevimabLong-term COVID-19 outcomesSustained recoveryPresenter:Renslow Sherer, MDDirectorInternational HIV Training CenterProfessor of MedicineSection of Infectious Diseases and Global HealthDepartment of

en

00:38:59

Racial Disparities in COVID-19: Causes, Consequences,...

Decera Clinical Education Infectious Disease Podcast ·

2021/10/29

In this episode, Oni Blackstock, MD, MHS, and Nina T. Harawa, PhD, MPH, discuss racial disparities in COVID-19 outcomes, including:Background on healthcare inequities among BIPOCCOVID-19 racial disparities and the healthcare inequities driving themOvercoming barriers to optimal COVID-19 care among BIPOCAddressing concerns about COVID-19 vaccination Motivational interviewing principles and the brief negotiated interview to earn trust and increase vaccine acceptancePresenters:Oni Blackstock, MD,

en

00:17:47

The Promise of Individualized HIV Prevention: Future...

Decera Clinical Education Infectious Disease Podcast ·

2021/10/21

In this episode, Nicholas Chamberlain, MD, provides an overview of the different antiretroviral drug formulations and dosing strategies in various stages of clinical development for long-acting HIV PrEP—advances that collectively offer the potential for highly individualized approaches to HIV biomedical prevention.Presenter:Nicholas Chamberlain, MDMedical DirectorAHF Healthcare Center – Atlanta MidtownDepartment of MedicineAIDS Healthcare FoundationAtlanta, GeorgiaContent based on an online CME

en

00:18:04

A Long Journey to HCV Cure: Conversations Between...

Decera Clinical Education Infectious Disease Podcast ·

2021/10/19

In episode 1 of an ongoing series of conversations between a physician and patient, Stacey Trooskin, MD, PhD, MPH, and patient advocate Brother Dan Palmer discuss approaches to improve access to HCV therapy. The conversation focuses on how barriers to care affected Dan’s health after his hepatitis C diagnosis and the strategies he employed to overcome them.Presenter:Stacey Trooskin, MD, PhD, MPH Chief Medical Officer Philadelphia FIGHT Community Health CentersFacultyDivision of Infectious

en

00:42:18

New COVID-19 Data: A Case for Optimism?

Decera Clinical Education Infectious Disease Podcast ·

2021/10/14

In this podcast episode, Paul E. Sax, MD, and Renslow Sherer, MD, discuss the clinical significance of new data on the prevention and treatment of COVID-19, including:COVID-19 in immunocompromised hostsPrime-Boost Strategy for COVID-19 vaccinationCOVID-19 surge effectsMonoclonal antibody therapy for prevention and treatmentRemdesivir updateRepurposed drug, fluvoxamineWhat does the future of the pandemic look like?Presenters:Paul E. Sax, MDClinical DirectorHIV Program and Division of Infectious

en

00:10:15

Key Decisions in HIV Care: What to Do About Missed...

Decera Clinical Education Infectious Disease Podcast ·

2021/10/13

In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, explores recommendations and data to support the management of missed CAB plus RPV injections.Listen as she gives her perspectives on:Prescribing information recommendations for managing missed injections of CAB plus RPVPharmacokinetic modeling data to support management strategies for missed injectionsData from the ATLAS and FLAIR studies on missed injections and patient outcomesPresenter:Milena Murray, PharmD, MSc, BCIDP, AAHIVPAssociate

en

00:10:42

Key Decisions in HIV Care: Considerations for...

Decera Clinical Education Infectious Disease Podcast ·

2021/10/12

In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, explores recommendations and data on maternal weight gain associated with ART use in pregnancy.Listen as she gives her perspectives on:IMPAACT 2010 data on maternal weight gain with DTG + FTC/TAF vs DTG + FTC/TDF vs EFV/FTC/TDFSMARTT study data on gestational weight gain by ART classTsepamo Surveillance study data on maternal weight and birth outcomes among women receiving ART, as well as weight outcomes with DTG vs EFVDHHS Perinatal

en

00:41:36

Key HIV Studies Influencing My Practice Following...

Decera Clinical Education Infectious Disease Podcast ·

2021/10/11

In this episode, Darcy Wooten, MD, discusses new HIV data from IDWeek 2021, including:A rapid test-and-treat program to start DTG/3TC in patients newly diagnosed with HIV (STAT)Efficacy when switching from 3-drug to 4-drug TAF-based regimens to DTG/3TC (TANGO)Virologic outcomes with 2-drug vs 3-drug ART regimens (Trio Health HIV Network Study)Metabolic complications in treatment-naive patients (Study 1489 and Study 1490)Resistance analysis of an investigational agent, lenacapavir (CALIBRATE)The

en

00:43:55

Audio Recap: Timely Treatment for COVID-19

Decera Clinical Education Infectious Disease Podcast ·

2021/10/11

During this episode, Lynora Saxinger, MD, FRCPC, CTropMed, updates listeners on the latest Emergency Use Authorizations and guideline recommendations for optimal clinical management of COVID-19. Gain practical insights on patient identification, risk stratification, and treatment.Key points include:Treatment of COVID-19 can be broken into antiviral and immune-modulating therapiesEach agent should be used at the correct disease stage to maximize benefitAntiviral medications and mAbs show the greatest

en

00:41:07

Key Decisions in HIV Care: Rapid Initiation of ART

Decera Clinical Education Infectious Disease Podcast ·

2021/09/29

In this episode from the series “Key Decisions in HIV Care,” Jason Halperin, MD, MPH, and Jürgen K. Rockstroh, MD, discuss important considerations in the rapid initiation of ART, including guideline recommendations and data supporting recommended ART regimen options for rapid initiation and emerging data for the 2-drug regimen dolutegravir/lamivudine for rapid start from the STAT study. Following their dialogue, the faculty field questions from healthcare professionals.Presenters:Jason Halperin,

en

00:09:45

Key Decisions in HIV Care: Tenofovir Alafenamide in...

Decera Clinical Education Infectious Disease Podcast ·

2021/09/29

In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, explores the data to support the use of tenofovir alafenamide in pregnancy.Listen as she gives her perspectives on:DHHS guideline recommendations for the use of TAF in pregnancyPharmacokinetic data to support adequate TAF concentrations throughout pregnancyAvailable antiretroviral pregnancy registry information on the use of TAF in pregnancyData from the IMPAACT 2010 study to support the use of a TAF-containing regimen in

en

00:07:46

Shingles in the COVID-19 Era: Risk Factors and...

Decera Clinical Education Infectious Disease Podcast ·

2021/09/24

In this episode, Tracy Zivin-Tutela, MD, discusses factors that put your patients at risk for shingles and its complications.Tracy Zivin-Tutela, MDInfectious Diseases SpecialistDepartment of Infectious DiseasesFountain Valley Regional HospitalLos Alamitos Medical CenterFountain Valley, CaliforniaUsing a case study and the latest data, this podcast covers topics such as: Pathophysiology and epidemiologyDisease burden and potential complications in older patients, including postherpetic neuralgiaRisk

en

00:11:52

Key Decisions in HIV Care: Considering Rapid ART in a...

Decera Clinical Education Infectious Disease Podcast ·

2021/09/23

In this episode, Jason Halperin, MD, MPH, explores the data to support rapid ART initiation in patients with OUD.Listen as he gives his perspectives on:DHHS guidelines for rapid initiation of ART and specific recommendations for patients with substance use disordersSAMSHA recommendations for the treatment of OUDMedications that are recommended for the treatment of OUD, including drug–drug interaction considerations with ARTData to support the treatment of OUD to improve HIV viral suppression ratesIn

en

00:11:32

Key Decisions in HIV Care: Initiating Timely ART in a...

Decera Clinical Education Infectious Disease Podcast ·

2021/09/23

In this episode, Jason Halperin, MD, MPH, explores the data to support rapid ART initiation in adolescent patients.Listen as he gives his perspectives on:DHHS and IAS-USA guidelines for rapid initiation and specific recommendations for adolescents and young adultsCrescentCare data comparing the virologic outcomes for patients 18-24 years of age compared with those aged 25 years or olderData to suggest that rapid ART upholds equityIn addition, hear his patient’s perspective on the importance of rapid

en

00:15:03

Emerging Long-Acting PrEP Options

Decera Clinical Education Infectious Disease Podcast ·

2021/09/16

In this episode, Colleen Kelley, MD, MPH, discusseskey features and available safety and efficacy data on investigational long-acting HIV pre-exposure prophylaxis strategies that are in late stages of clinical development.Presenter:Colleen Kelley, MD, MPHAtlanta, Georgia Colleen Kelley, MD, MPH, has disclosed that she has received funds for research support from Gilead Sciences, Moderna, Novavax, and ViiV Healthcare. Content based on an online CME program supported by an independent educational

en

00:42:25

Contemporary Management of HIV 2021: New Data From...

Decera Clinical Education Infectious Disease Podcast ·

2021/09/14

In this second of 2 episodes, Shobha Swaminathan, MD, and Eric S. Daar, MD, review key data influencing their practice following the IAS 2021 Conference, including data on investigational antiretroviral agents, lenacapavir and islatravir, and alternative dosing of BPaL for MDR-TB. This episode includes discussion of:An extension of FLAIR, demonstrating virologic efficacy and safety of long-acting CAB plus RPV at Week 124A Week 26 safety and efficacy analysis of CAPELLA, a study of lenacapavir in

en

00:43:11

The Monoclonal Antibodies Strike Back: New Data on...

Decera Clinical Education Infectious Disease Podcast ·

2021/09/14

In this podcast episode, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, and Arthur Kim, MD, discuss data on the potential use of monoclonal antibodies (mAb) for the prevention and treatment of COVID-19, including:Rationale for use of mAbPotential for resistance to mAbSingle vs combination therapy with mAbChallenges in implementation of mAb as treatment or preventionBamlanivimabSotrovimabCasirivimab plus imdevimabLink to full program, including downloadable slidesets:

en

00:29:31

Contemporary Management of HIV 2021: New Data From...

Decera Clinical Education Infectious Disease Podcast ·

2021/09/08

In this first of 2 episodes, Shobha Swaminathan, MD, and Eric S. Daar, MD, review key data influencing their practice following the IAS 2021 Conference, including results from studies on HIV and COVID-19 outcomes; virologic and metabolic outcomes of DTG/3TC; long-acting CAB plus RPV for ART in treatment-naive PWH. This episode includes discussion of:A Global Clinical Platform that evaluated outcomes of PWH hospitalized with COVID-19A post hoc analysis of TANGO, evaluating the virologic and

en

00:16:01

Contemporary Management of HIV 2021: Heavily...

Decera Clinical Education Infectious Disease Podcast ·

2021/09/07

In this series of 3 episodes, Geeta Gupta, MD, discusses strategies for optimizing ART in heavily treatment–experienced patients with HIV, including management of virologic failure and switching ART in virologically suppressed patients with underlying resistance. The 3 episodes will include analyses from:BENCHMRK, which demonstrated that the number of active drugs predicts outcomes in treatment-experienced patientsTMB-301, a study that added the monoclonal antibody ibalizumab in pretreated patients

en

498 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College